Sunshine Biopharma Inc. - Common stock (SBFM) analyst actions
Rating and price-target actions on SBFM in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SBFM overview →
1 measured SBFM analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing | Press release | -9.07% | -15.96% |
Keep exploring
More SBFM: earnings → · SEC filings → · SBFM overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SOL GLOBAL INVTS CORP (SOLCF) | 179 | 0.00% | 49% |
| Heartbeam, Inc. (BEAT) | 178 | -0.55% | 43% |
| Cardax, Inc. (CDXI) | 177 | 0.00% | 13% |
| NRC Health (NRC) | 177 | -0.16% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.